Table 2.
Severity of Coronary Artery Disease and Interventional Details
| Variable | Clopidogrel (n=552) | Ticagrelor (n=535) | P Value |
|---|---|---|---|
| No. of coronary vessels diseased, % | |||
| 1 | 27.5 | 26.4 | 0.6 |
| 2 | 34.1 | 31.4 | 0.3 |
| 3 | 38.3 | 42.2 | 0.18 |
| Initial TIMI 0 flow, % | 69.5 | 62.7 | 0.04 |
| Thrombaspiration, % | 6.1 | 13.3 | <0.01 |
| No. of stents implanted, mean±SD | 1.33±0.6 | 1.49±0.8 | <0.01 |
| Glycoprotein IIb/IIIa antagonists, % | 63.7 | 42.2 | <0.01 |
| Type of stent, % | |||
| Bare metal stent | 89.1 | 21.4 | <0.01 |
| Drug‐eluting stent | 10.8 | 76.7 | <0.01 |
| PCI result (TIMI flow), % | |||
| TIMI flow 0/1 | 2.9 | 3.6 | 0.5 |
| TIMI flow 2 | 8.3 | 7.6 | 0.6 |
| TIMI flow 3 | 88.6 | 88.7 | 0.9 |
| Peak CK, mean±SD, U/mL | 1660±1742 | 1499±1515 | 0.1 |
| Peak CK >2000 U/mL, % | 29.1 | 26.9 | 0.5 |
| LVEF after STEMI, mean±SD, % | 45.9±9 | 47.0±9.5 | 0.16 |
| LVEF <40%, % | 18.1 | 16.1 | 0.2 |
CK indicates creatine kinase; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction.